Clinical Trial Update: A Study of Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic/pharmacodynamic study of orally administered leuprolide in healthy female volunteers completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Leuprolide (Leuprolide acetate)

Snippet

Sponsor: Enteris BioPharma Inc. | Conditions: Endometriosis | Phase 2 | Status: COMPLETED | Results posted: 2022-02-11